The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs
Detection of Δ9 THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: an evaluation of two point-of-collection testing devices
New publication out now, examining the accuracy of two commonly used point-of-collection testing devices in detecting oral fluid THC. Tests were performed at fixed intervals over 3 hours, yielding a total of over 300 tests. Both devices produces a surprisingly high number of false positives and false negatives. By 180 min, all samples contained less… Continue reading Detection of Δ9 THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: an evaluation of two point-of-collection testing devices
MDMA- and psilocybin-assisted therapy discussion panel, Helsinki, Finland
Dr. Kim Kuypers and Natasha Mason were invited to speak at and participate in an event in Helsinki, Finland, discussing research on the therapeutic potential and mechanisms of action of psilocybin and MDMA. The panel discussion has now been posted, and can be viewed here.
Nieuwe studie zoekt deelnemers aan een onderzoek met een nieuw psychedelisch onderzoeksmedicijn voor behandeling van depressie
EEN KLINISCH ONDERZOEK MET VRIJWILLIGERS DIE EEN PSYCHEDELISCH ONDERZOEKSMEDICIJN WILLEN PROBEREN OM EEN DEPRESSIEVE STOORNIS TE BEHANDELEN We zijn op zoek naar volwassenen met een depressie die eerder onvoldoende effect hebben ondervonden van ten minste twee verschillende behandelingen (bijvoorbeeld antidepressieve medicatie, psychotherapie). Het onderzoek vindt plaats in Maastricht en bestaat uit een telefonisch overleg om… Continue reading Nieuwe studie zoekt deelnemers aan een onderzoek met een nieuw psychedelisch onderzoeksmedicijn voor behandeling van depressie
Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.
Most street cannabis contains large quantities of THC, the chemical in cannabis that gets people ‘high’, but there is increasing use of medicinal products that also contain CBD, a non-intoxicating cannabinoid with promising therapeutically potential. It has often been proposed that administering CBD may reduce some of the impairment caused by THC. To test this,… Continue reading Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.
The Good, the Bad and the Intoxicated
Pint of Science is coming to the Netherlands this year, and we will be sharing some of our research! If you are in the Maastricht area on May 20th, come to Cafe Charlemagne to hear about "the good, the bad, and the intoxicated". For full event info, check out the website.
